Eli Lilly
LLY
LLY
2,599 hedge funds and large institutions have $270B invested in Eli Lilly in 2023 Q1 according to their latest regulatory filings, with 152 funds opening new positions, 1,058 increasing their positions, 995 reducing their positions, and 153 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,599
Holders Change
-58
Holders Change %
-2.18%
% of All Funds
41.6%
Holding in Top 10
151
Holding in Top 10 Change
-46
Holding in Top 10 Change %
-23.35%
% of All Funds
2.42%
New
152
Increased
1,058
Reduced
995
Closed
153
Calls
$2.16B
Puts
$2.03B
Net Calls
+$135M
Net Calls Change
+$395M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$882M |
| 2 |
Edgewood Management
Greenwich,
Connecticut
|
+$729M |
| 3 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$456M |
| 4 |
Amundi
Paris,
France
|
+$405M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$356M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$1.75B |
| 2 |
M1FG
Mach-1 Financial Group
Rogers,
Arkansas
|
-$1.6B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.18B |
| 4 |
Jennison Associates
New York
|
-$637M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$592M |